MCQs for discussion for competitive exams nepal 2024 2025

MCQs for discussion for competitive exams nepal


A 50-year-old woman presents with severe epigastric pain that radiates to her back and is relieved by leaning forward. Laboratory tests show elevated serum amylase and lipase. What is the most likely diagnosis?

  • A. Cholecystitis
  • B. Pancreatitis
  • C. Peptic ulcer disease
  • D. Myocardial infarction
  • E. Gastritis

A 72-year-old man with a history of chronic obstructive pulmonary disease (COPD) presents with worsening shortness of breath and a productive cough. His temperature is 38.5°C (101.3°F). A chest X-ray reveals an infiltrate in the right lower lobe. What is the most appropriate treatment?

  • A. Inhaled bronchodilators
  • B. Oral corticosteroids
  • C. Antibiotics
  • D. Diuretics
  • E. Anticoagulants

A 34-year-old woman presents with fatigue, muscle weakness, and craving for salty foods. Her blood pressure is 90/60 mm Hg. Laboratory tests show hyponatremia and hyperkalemia. What is the most likely diagnosis?

  • A. Hypothyroidism
  • B. Cushing’s syndrome
  • C. Addison’s disease
  • D. Hyperaldosteronism
  • E. Pheochromocytoma

Answers:

  1. B. Pancreatitis
  2. C. Antibiotics
  3. C. Addison’s disease

Conditions associated with tumor marker CA 19-9 increase serum levels

Conditions associated with increased serum levels of the tumor marker CA 19-9

Introduction

CA 19-9 is a protein found in the blood that can indicate certain cancers, especially pancreatic cancer. It’s considered a tumor marker, which means it’s produced by cancer cells or normal cells in response to cancer. While healthy individuals may have small amounts of CA 19-9, elevated levels often signal pancreatic cancer. However, high CA 19-9 can also occur in other cancers or non-cancerous conditions like gallstones or liver cirrhosis. The test isn’t used alone for diagnosis but helps monitor cancer and treatment effectiveness. If you’re undergoing cancer treatment or have been diagnosed with pancreatic cancer, your healthcare provider may use CA 19-9 tests to track progress and detect recurrence123 (ca 19.9).

Conditions associated with increased ca 19.9

Malignant
Pancreatic exocrine and neuroendocrine cancers
Biliary cancer (gallbladder, cholangiocarcinoma, ampullary cancers)
Hepatocellular cancer
Gastric, ovarian, colorectal cancer (less often)
Lung, breast, uterine cancer (rare)
Benign
Acute cholangitis
Cirrhosis and other cholestatic diseases (including gallstones)
CA 19-9: carbohydrate antigen 19-9.
Exit mobile version